Tapewire

Nasdaq · USD

IMVT

Immunovant, Inc.

Export transactions ↓
Tapewire entity
3632
SEC CIK
0001764013
Parsed reports
357

Last 12 months

Inside the activity.

1 purchase rows · 60 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202516
Jan 202603
Feb 202603
Mar 202601
Apr 202608
May 202607
Jun 2026010
Jul 2026012
Aug 202602
Sep 202601
Oct 202605

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 28, 2026 Filed May 29, 2026 20:04 UTC Exercise / conversionStock Option (right to buy) · Derivative 71,492 $0.00 Strike: $7.94 $0.00
Disclosure

SEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · derivative · entry 8

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 71,492 shares

Expires 2032-01-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Reflects an award of stock options to purchase Common Shares that is fully vested.

Read SEC document
May 28, 2026 Filed May 29, 2026 20:04 UTC Exercise / conversionStock Option (right to buy) · Derivative 31,668 $0.00 Strike: $4.99 $0.00
Disclosure

SEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · derivative · entry 7

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 31,668 shares

Expires 2032-08-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Reflects an award of stock options to purchase Common Shares that is fully vested.

Read SEC document
May 28, 2026 Filed May 29, 2026 20:04 UTC SaleCommon Stock 210,468 $33.56 $7,063,306.08
Disclosure

SEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · nonDerivative · entry 6

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,382

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.04 - $33.85 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
May 28, 2026 Filed May 29, 2026 20:04 UTC SaleCommon Stock 11,483 $32.64 $374,805.12
Disclosure

SEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · nonDerivative · entry 5

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 284,850

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.04 - $33.035 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
May 28, 2026 Filed May 29, 2026 20:04 UTC Exercise / conversionCommon Stock 16,260 $14.70 $239,022.00
Disclosure

SEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · nonDerivative · entry 4

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 28, 2026 Filed May 29, 2026 20:04 UTC Exercise / conversionCommon Stock 77,181 $8.43 $650,635.83
Disclosure

SEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · nonDerivative · entry 3

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 280,073

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 28, 2026 Filed May 29, 2026 20:04 UTC Exercise / conversionCommon Stock 71,492 $7.94 $567,646.48
Disclosure

SEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · nonDerivative · entry 2

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 202,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 28, 2026 Filed May 29, 2026 20:04 UTC Exercise / conversionCommon Stock 31,668 $4.99 $158,023.32
Disclosure

SEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · nonDerivative · entry 1

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2026 Filed May 21, 2026 01:22 UTC
Pande AtulDirector
Exercise / conversionStock Option (right to buy) · Derivative 6,000 $0.00 Strike: $8.43 $0.00
Disclosure

SEC source: 0001643071-26-000004 · wk-form4_1779326521.xml · derivative · entry 4

Pande Atul · CIK 0001643071 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 270,252

Underlying: Common Stock · 6,000 shares

Expires 2029-11-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025.

F2 · derivative.exercise_date: Reflects an award of stock options to purchase Common Shares that is fully vested.

Read SEC document
May 20, 2026 Filed May 21, 2026 01:22 UTC
Pande AtulDirector
SaleCommon Stock 6,000 $32.00 $192,000.00
Disclosure

SEC source: 0001643071-26-000004 · wk-form4_1779326521.xml · nonDerivative · entry 2

Pande Atul · CIK 0001643071 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,731

F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025.

Read SEC document
May 20, 2026 Filed May 21, 2026 01:22 UTC
Pande AtulDirector
Exercise / conversionCommon Stock 6,000 $8.43 $50,580.00
Disclosure

SEC source: 0001643071-26-000004 · wk-form4_1779326521.xml · nonDerivative · entry 1

Pande Atul · CIK 0001643071 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 122,731

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025.

Read SEC document
May 20, 2026 Filed May 22, 2026 20:03 UTC
Gloria MelanieChief Operating Officer
SaleCommon Stock 1,698 $32.95 $55,949.10
Disclosure

SEC source: 0001764013-26-000067 · wk-form4_1779480209.xml · nonDerivative · entry 3

Gloria Melanie · CIK 0001973838 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 242,107

F1 · shares: On November 18, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on May 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.55 - $33.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
May 20, 2026 Filed May 22, 2026 20:03 UTC
Gloria MelanieChief Operating Officer
SaleCommon Stock 1,168 $32.15 $37,551.20
Disclosure

SEC source: 0001764013-26-000067 · wk-form4_1779480209.xml · nonDerivative · entry 2

Gloria Melanie · CIK 0001973838 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,805

F1 · shares: On November 18, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on May 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.55 - $32.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
May 20, 2026 Filed May 22, 2026 20:03 UTC
Gloria MelanieChief Operating Officer
SaleCommon Stock 249 $30.41 $7,572.09
Disclosure

SEC source: 0001764013-26-000067 · wk-form4_1779480209.xml · nonDerivative · entry 1

Gloria Melanie · CIK 0001973838 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 244,973

F1 · shares: On November 18, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on May 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.32 - $31.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
May 01, 2026 Filed May 1, 2026 22:40 UTC SaleCommon Stock 2,502 $27.17 $67,979.34
Disclosure

SEC source: 0001764013-26-000058 · wk-form4_1777675214.xml · nonDerivative · entry 1

Susman Robert Graham · CIK 0002065992 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,394

F1 · shares: The transaction reported on this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.84 - $27.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
April 23, 2026 Filed Apr 24, 2026 20:07 UTC
Girao TiagoChief Financial Officer
SaleCommon Stock 25,760 $29.62 $763,011.20
Disclosure

SEC source: 0001764013-26-000056 · wk-form4_1777061232.xml · nonDerivative · entry 1

Girao Tiago · CIK 0001618670 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 247,596

F1 · shares: On May 1, 2025, the holder was granted 208,388 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on May 5, 2025, of which 52,097 of these RSUs vested on April 21, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.23 - $30.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
April 23, 2026 Filed Apr 24, 2026 20:05 UTC
Stout Jay SChief Technology Officer
SaleCommon Stock 2,754 $29.62 $81,573.48
Disclosure

SEC source: 0001764013-26-000055 · wk-form4_1777061153.xml · nonDerivative · entry 1

Stout Jay S · CIK 0001702969 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 251,685

F1 · shares: On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on April 17, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.23 - $30.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:03 UTC
Gloria MelanieChief Operating Officer
SaleCommon Stock 8,722 $24.83 $216,567.26
Disclosure

SEC source: 0001973838-26-000004 · wk-form4_1775851435.xml · nonDerivative · entry 1

Gloria Melanie · CIK 0001973838 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 245,222

F1 · shares: On April 1, 2025, the holder was granted 76,181 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 3, 2025, of which 19,045 of these RSUs vested on April 1, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.54 - $25.39 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:05 UTC
Van Tuyl ChristopherChief Legal Officer
SaleCommon Stock 5,165 $24.83 $128,246.95
Disclosure

SEC source: 0001779707-26-000004 · wk-form4_1775851530.xml · nonDerivative · entry 1

Van Tuyl Christopher · CIK 0001779707 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,231

F1 · shares: On April 1, 2025, the holder was granted 50,787 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 3, 2025, of which 12,696 of these RSUs vested on April 1, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.54 - $25.39 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:02 UTC
Stout Jay SChief Technology Officer
SaleCommon Stock 1,518 $24.83 $37,691.94
Disclosure

SEC source: 0001702969-26-000006 · wk-form4_1775851354.xml · nonDerivative · entry 2

Stout Jay S · CIK 0001702969 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254,439

F3 · shares: On April 2, 2024, the holder was granted 54,978 RSUs, as previously reported on a Form 4 filed on April 4, 2024, of which 3,436 of these RSUs vested on April 2, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.54 - $25.39 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:02 UTC
Stout Jay SChief Technology Officer
SaleCommon Stock 8,614 $24.83 $213,885.62
Disclosure

SEC source: 0001702969-26-000006 · wk-form4_1775851354.xml · nonDerivative · entry 1

Stout Jay S · CIK 0001702969 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 255,957

F1 · shares: On April 1, 2025, the holder was granted 76,181 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 3, 2025, of which 19,045 of these RSUs vested on April 1, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.54 - $25.39 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:22 UTC GrantStock Option (right to buy) · Derivative 7,061 $0.00 Strike: $24.61 $0.00
Disclosure

SEC source: 0001764013-26-000042 · wk-form4_1775766147.xml · derivative · entry 2

Susman Robert Graham · CIK 0002065992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,061

Underlying: Common Stock · 7,061 shares

Expires 2036-04-07

F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:22 UTC GrantCommon Stock 13,880 $0.00 $0.00
Disclosure

SEC source: 0001764013-26-000042 · wk-form4_1775766147.xml · nonDerivative · entry 1

Susman Robert Graham · CIK 0002065992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,896

F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:20 UTC
Gloria MelanieChief Operating Officer
GrantStock Option (right to buy) · Derivative 121,063 $0.00 Strike: $24.61 $0.00
Disclosure

SEC source: 0001764013-26-000040 · wk-form4_1775766037.xml · derivative · entry 2

Gloria Melanie · CIK 0001973838 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,063

Underlying: Common Stock · 121,063 shares

Expires 2036-04-07

F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:20 UTC
Gloria MelanieChief Operating Officer
GrantCommon Stock 83,671 $0.00 $0.00
Disclosure

SEC source: 0001764013-26-000040 · wk-form4_1775766037.xml · nonDerivative · entry 1

Gloria Melanie · CIK 0001973838 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 253,944

F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:13 UTC
Venker EricDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 336,043 $0.00 Strike: $24.61 $0.00
Disclosure

SEC source: 0001764013-26-000034 · wk-form4_1775765620.xml · derivative · entry 2

Venker Eric · CIK 0001801917 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 336,043

Underlying: Common Stock · 336,043 shares

Expires 2036-04-07

F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:13 UTC
Venker EricDirector · Chief Executive Officer
GrantCommon Stock 232,252 $0.00 $0.00
Disclosure

SEC source: 0001764013-26-000034 · wk-form4_1775765620.xml · nonDerivative · entry 1

Venker Eric · CIK 0001801917 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 251,813

F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:31 UTC
Torti FrankDirector
GrantStock Option (right to buy) · Derivative 88,325 $0.00 Strike: $24.61 $0.00
Disclosure

SEC source: 0001764013-26-000052 · wk-form4_1775766671.xml · derivative · entry 2

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,325

Underlying: Common Stock · 88,325 shares

Expires 2036-04-07

F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest in substantially equal quarterly installments over two years measured from April 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:31 UTC
Torti FrankDirector
GrantCommon Stock 174,189 $0.00 $0.00
Disclosure

SEC source: 0001764013-26-000052 · wk-form4_1775766671.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,009,228

F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. These units will vest in substantially equal quarterly installments over two years measured from April 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:28 UTC GrantStock Option (right to buy) · Derivative 7,061 $0.00 Strike: $24.61 $0.00
Disclosure

SEC source: 0001764013-26-000050 · wk-form4_1775766526.xml · derivative · entry 2

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,061

Underlying: Common Stock · 7,061 shares

Expires 2036-04-07

F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:28 UTC GrantCommon Stock 13,880 $0.00 $0.00
Disclosure

SEC source: 0001764013-26-000050 · wk-form4_1775766526.xml · nonDerivative · entry 1

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,732

F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:25 UTC
Pande AtulDirector
GrantStock Option (right to buy) · Derivative 7,061 $0.00 Strike: $24.61 $0.00
Disclosure

SEC source: 0001764013-26-000046 · wk-form4_1775766313.xml · derivative · entry 3

Pande Atul · CIK 0001643071 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,061

Underlying: Common Stock · 7,061 shares

Expires 2036-04-07

F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:25 UTC
Pande AtulDirector
GrantCommon Stock 13,880 $0.00 $0.00
Disclosure

SEC source: 0001764013-26-000046 · wk-form4_1775766313.xml · nonDerivative · entry 1

Pande Atul · CIK 0001643071 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,731

F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:26 UTC GrantStock Option (right to buy) · Derivative 7,061 $0.00 Strike: $24.61 $0.00
Disclosure

SEC source: 0001764013-26-000048 · wk-form4_1775766410.xml · derivative · entry 2

Hughes Douglas J. · CIK 0001710863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,061

Underlying: Common Stock · 7,061 shares

Expires 2036-04-07

F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:26 UTC GrantCommon Stock 13,880 $0.00 $0.00
Disclosure

SEC source: 0001764013-26-000048 · wk-form4_1775766410.xml · nonDerivative · entry 1

Hughes Douglas J. · CIK 0001710863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,653

F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:23 UTC
Bauer JakeDirector
GrantStock Option (right to buy) · Derivative 7,061 $0.00 Strike: $24.61 $0.00
Disclosure

SEC source: 0001764013-26-000044 · wk-form4_1775766231.xml · derivative · entry 2

Bauer Jake · CIK 0001654909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,061

Underlying: Common Stock · 7,061 shares

Expires 2036-04-07

F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:23 UTC
Bauer JakeDirector
GrantCommon Stock 13,880 $0.00 $0.00
Disclosure

SEC source: 0001764013-26-000044 · wk-form4_1775766231.xml · nonDerivative · entry 1

Bauer Jake · CIK 0001654909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,896

F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:19 UTC
Stout Jay SChief Technology Officer
GrantStock Option (right to buy) · Derivative 96,851 $0.00 Strike: $24.61 $0.00
Disclosure

SEC source: 0001764013-26-000038 · wk-form4_1775765943.xml · derivative · entry 2

Stout Jay S · CIK 0001702969 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,851

Underlying: Common Stock · 96,851 shares

Expires 2036-04-07

F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:19 UTC
Stout Jay SChief Technology Officer
GrantCommon Stock 66,937 $0.00 $0.00
Disclosure

SEC source: 0001764013-26-000038 · wk-form4_1775765943.xml · nonDerivative · entry 1

Stout Jay S · CIK 0001702969 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 264,571

F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:17 UTC
Van Tuyl ChristopherChief Legal Officer
GrantStock Option (right to buy) · Derivative 59,820 $0.00 Strike: $24.61 $0.00
Disclosure

SEC source: 0001764013-26-000036 · wk-form4_1775765844.xml · derivative · entry 2

Van Tuyl Christopher · CIK 0001779707 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,820

Underlying: Common Stock · 59,820 shares

Expires 2036-04-07

F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:17 UTC
Van Tuyl ChristopherChief Legal Officer
GrantCommon Stock 41,343 $0.00 $0.00
Disclosure

SEC source: 0001764013-26-000036 · wk-form4_1775765844.xml · nonDerivative · entry 1

Van Tuyl Christopher · CIK 0001779707 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,396

F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:10 UTC
Girao TiagoChief Financial Officer
GrantStock Option (right to buy) · Derivative 94,002 $0.00 Strike: $24.61 $0.00
Disclosure

SEC source: 0001764013-26-000032 · wk-form4_1775765429.xml · derivative · entry 2

Girao Tiago · CIK 0001618670 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,002

Underlying: Common Stock · 94,002 shares

Expires 2036-04-07

F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 07, 2026 Filed Apr 9, 2026 20:10 UTC
Girao TiagoChief Financial Officer
GrantCommon Stock 64,968 $0.00 $0.00
Disclosure

SEC source: 0001764013-26-000032 · wk-form4_1775765429.xml · nonDerivative · entry 1

Girao Tiago · CIK 0001618670 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 273,356

F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 02, 2026 Filed Apr 3, 2026 20:33 UTC
Venker EricDirector · Chief Executive Officer
SaleCommon Stock 1,409 $24.60 $34,661.40
Disclosure

SEC source: 0001764013-26-000024 · wk-form4_1775248378.xml · nonDerivative · entry 4

Venker Eric · CIK 0001801917 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,561

F3 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these CVARs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.51 - $24.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
April 02, 2026 Filed Apr 3, 2026 20:33 UTC
Venker EricDirector · Chief Executive Officer
SaleCommon Stock 12,820 $24.04 $308,192.80
Disclosure

SEC source: 0001764013-26-000024 · wk-form4_1775248378.xml · nonDerivative · entry 3

Venker Eric · CIK 0001801917 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,970

F3 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these CVARs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.50 - $24.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:33 UTC
Venker EricDirector · Chief Executive Officer
Exercise / conversionCapped Value Appreciation Rights · Derivative 368,750 $0.00 Strike: $14.46 $0.00
Disclosure

SEC source: 0001764013-26-000024 · wk-form4_1775248378.xml · derivative · entry 5

Venker Eric · CIK 0001801917 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,106,250

Underlying: Common Stock · 368,750 shares

Expires 2030-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date.

F2 · derivative.exercise_price: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026.

F1 · kind: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date.

F2 · kind: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026.

F1 · shares: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date.

F2 · shares: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026.

F2 · derivative.exercise_date: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026.

F6 · derivative.exercise_date: These CVARs vest on the first date that each of (i) the Service Requirement, (ii) the Performance Requirement, and (iii) the Knock-in Requirement have been satisfied. The "Service Requirement" is satisfied as follows: (i) 25% of the CVARs vested on April 1, 2026; and (ii) the remaining 75% vests in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer or an affiliate on each such vesting date. The "Performance Requirement" is tied to the achievement of a specified clinical development activity at the Issuer, which requirement was met as of March 31, 2026. The "Knock-in Requirement" requires that the price of the Issuer's common stock at each applicable vesting date must be equal to or greater than $16.76 per share.

F1 · derivative.underlying_shares: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date.

F2 · derivative.underlying_shares: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:33 UTC
Venker EricDirector · Chief Executive Officer
Disposition to issuerCommon Stock 334,960 $25.10 $8,407,496.00
Disclosure

SEC source: 0001764013-26-000024 · wk-form4_1775248378.xml · nonDerivative · entry 2

Venker Eric · CIK 0001801917 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,790

F1 · kind: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date.

F2 · kind: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026.

F1 · shares: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date.

F2 · shares: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026.

F1 · price: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date.

F2 · price: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:33 UTC
Venker EricDirector · Chief Executive Officer
Exercise / conversionCommon Stock 368,750 $14.46 $5,332,125.00
Disclosure

SEC source: 0001764013-26-000024 · wk-form4_1775248378.xml · nonDerivative · entry 1

Venker Eric · CIK 0001801917 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date.

F2 · kind: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026.

F1 · shares: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date.

F2 · shares: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026.

F1 · price: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date.

F2 · price: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026.

Read SEC document
March 18, 2026 Filed Mar 20, 2026 20:11 UTC
Van Tuyl ChristopherChief Legal Officer
SaleCommon Stock 2,877 $24.97 $71,838.69
Disclosure

SEC source: 0001764013-26-000015 · wk-form4_1774037475.xml · nonDerivative · entry 1

Van Tuyl Christopher · CIK 0001779707 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,053

F1 · shares: On December 16, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on December 18, 2024, of which 6,872 of these RSUs vested on March 16, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:07 UTC
Gloria MelanieChief Operating Officer
SaleCommon Stock 942 $28.90 $27,223.80
Disclosure

SEC source: 0001764013-26-000013 · wk-form4_1772226458.xml · nonDerivative · entry 3

Gloria Melanie · CIK 0001973838 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,273

F1 · shares: On November 18, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on February 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.70 - $29.13 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.